MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

Search

Merit Medical Systems Inc

Ouvert

SecteurSoins de santé

83.2 0.68

Résumé

Variation du prix de l'action

24h

Actuel

Min

81.99

Max

83.86

Chiffres clés

By Trading Economics

Revenu

-4.8M

28M

Ventes

1.7M

384M

P/E

Moyenne du Secteur

42.21

89.037

Marge bénéficiaire

7.225

Employés

7,400

EBITDA

-4.4M

80M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+28.68% upside

Dividendes

By Dow Jones

Prochains Résultats

24 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-20M

4.9B

Ouverture précédente

82.52

Clôture précédente

83.2

Sentiment de l'Actualité

By Acuity

50%

50%

177 / 360 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Merit Medical Systems Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

21 janv. 2026, 23:49 UTC

Principaux Mouvements du Marché

Karman Space & Defense Shares Rise as 2026 Forecast Tops Analyst Estimates

21 janv. 2026, 21:12 UTC

Principaux Mouvements du Marché

Automaker Stocks Rise After Trump Calls Off European Tariffs

21 janv. 2026, 21:00 UTC

Acquisitions, Fusions, Rachats

Deutsche Borse Group to Acquire Allfunds for $6.19 Billion

21 janv. 2026, 20:29 UTC

Principaux Mouvements du Marché

Chip Makers Gain After Trump Calls Off European Tariffs

21 janv. 2026, 20:04 UTC

Principaux Mouvements du Marché

Apparel, Footwear Stocks Rise After Trump Calls Off European Tariffs

21 janv. 2026, 23:48 UTC

Market Talk

Nikkei May Rise as U.S.-Europe Tensions Ease -- Market Talk

21 janv. 2026, 23:34 UTC

Market Talk

Gold Falls Amid Easing U.S.-Europe Tensions Over Greenland -- Market Talk

21 janv. 2026, 22:39 UTC

Résultats

Schwab's Profit Jumps on Surge in Brokerage Activity -- 2nd Update

21 janv. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

21 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21 janv. 2026, 21:35 UTC

Acquisitions, Fusions, Rachats

Tesla Stock In Focus as Musk and Ryanair Chief Trade Insults. Should Investors Worry? -- Barrons.com

21 janv. 2026, 21:19 UTC

Résultats

Charles Schwab Earnings Miss Estimates. The Stock Is Rising Anyway. -- Barrons.com

21 janv. 2026, 20:45 UTC

Acquisitions, Fusions, Rachats

Deutsche Borse Group to Acquire Allfunds for $6.19B

21 janv. 2026, 20:36 UTC

Market Talk

U.S. Natural Gas Posts Back-to-Back Hefty Gains -- Market Talk

21 janv. 2026, 20:31 UTC

Market Talk

Oil Settles Higher With Support From Heating Fuel -- Market Talk

21 janv. 2026, 20:27 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse Expects Combined Company Will Be Able to Achieve Annual Run Rate Pretax Cost Synergies of About EUR60M

21 janv. 2026, 20:27 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21 janv. 2026, 20:27 UTC

Market Talk

Was It a 'TACO' Event? -- Market Talk

21 janv. 2026, 20:26 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse Has Received Irrevocable Undertakings in Support of Acquisition in Respect of About 48.9% of Allfunds Issued Share Capital Excluding Treasury Shares

21 janv. 2026, 20:23 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse: Allfunds Stockholders to Receive EUR8.80/Shr, Including Cash, Stock and Permitted Dividend

21 janv. 2026, 20:21 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse: Agreement Values Allfunds at About EUR5.3B

21 janv. 2026, 20:19 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse Group Agrees to Buy Allfunds

21 janv. 2026, 20:08 UTC

Résultats

Prologis Revenue Climbs as Warehouse Demand Rebounds -- Update

21 janv. 2026, 20:03 UTC

Market Talk

Precious Metals Drop After Trump Posts About Greenland Deal -- Market Talk

21 janv. 2026, 19:51 UTC

Market Talk

Treasury Markets React to Trump's Softer Tone About Greenland -- Market Talk

21 janv. 2026, 19:43 UTC

Market Talk

U.S. Ethanol Production Expected to Slip -- Market Talk

21 janv. 2026, 19:31 UTC

Market Talk

Gold Settles at Fresh All-Time High -- Market Talk

21 janv. 2026, 19:24 UTC

Résultats

Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls. -- Barrons.com

21 janv. 2026, 19:10 UTC

Market Talk

Mexican Inflation Seen Picking Up in Early January -- Market Talk

21 janv. 2026, 18:57 UTC

Market Talk

DAVOS: IBM CEO Krishna Says World Is More Volatile Now -- Market Talk

Comparaison

Variation de prix

Merit Medical Systems Inc prévision

Objectif de Prix

By TipRanks

28.68% hausse

Prévisions sur 12 Mois

Moyen 105.13 USD  28.68%

Haut 122 USD

Bas 90 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

8 ratings

7

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

95.585 / 96.35Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

177 / 360Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
help-icon Live chat